Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Anticancer Research|March 10, 2015
Biomarkers of apoptosis and necrosis in patients with hepatocellular carcinoma treated with sorafenibCorinne Godin, Christophe Louandre, Sandra Bodeau, et al.
Plos Pathogens|May 6, 2010
Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membraneGrazyna Domańska, Christian Motz, Michael Meinecke, et al.
Oncotarget|March 2, 2018
Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cellsChloé Sauzay, Christophe Louandre, Sandra Bodeau, et al.
Cancer Letters|November 8, 2015
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Albane Gicquel, Flora Bochereau, et al.
Molecular Cancer Research : MCR|July 22, 2010
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.
Molecular Cancer|May 18, 2016
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Catherine François, Chloé Sauzay, et al.
Atherosclerosis|May 16, 2013
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic miceIgor G Nikolov, Nobuhiko Joki, Antoine Galmiche, et al.
Biochemical Pharmacology|August 10, 2010
Chain-dependent photocytotoxicity of tricationic porphyrin conjugates and related mechanisms of cell death in proliferating human skin keratinocytesJoão Nuno Silva, Antoine Galmiche, João P C Tomé, et al.
Plos One|December 31, 2013
Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progressionIngrid Marcq, Rémy Nyga, Flora Cartier, et al.
Pageof 8